Skip to main content

2 Result(s)

within Christian Wilhelm Remove this filter Medicine & Public Health Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial

    First-line rituximab therapy together with chemotherapy is the standard care for patients with advanced follicular B-cell lymphoma, as rituximab together with chemotherapy prolongs progression-free and overall...

    Laura Budau, Christian Wilhelm, Roland Moll… in Journal of Cancer Research and Clinical On… (2019)

    Download PDF (769 KB) View Article

  2. No Access

    Article

    Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

    PTCL patients exhibit poor survival with existing treatments. We investigated the efficacy of CHOP combined with alemtuzumab in 116 PTCL patients age 61–80 in an open-label, randomized phase 3 trial. Alemtuzum...

    Gerald G. Wulf, Bettina Altmann, Marita Ziepert, Francesco D’Amore… in Leukemia (2021)